Inflammation and acne: Putting the pieces together

Journal of Drugs in Dermatology

Volumn 13, Issue 4, 2014, Pages 459-463

  Harvey, Alison ^a   Huynh, Tu T ^a  

^a Galderma Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CHEMOKINE; CYTOKINE; GROWTH FACTOR; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR; GROWTH HORMONE; PRASTERONE SULFATE; SOMATOMEDIN C;

ACNE VULGARIS; ARTICLE; BACTERIAL COLONIZATION; CELL TYPE; DISEASE COURSE; HUMAN; INFLAMMATION; MACROPHAGE; MONOCYTE; PATHOGENESIS; PROPIONIBACTERIUM ACNES; SEBUM; SEBUM SECRETION; T LYMPHOCYTE; BLOOD; COMPLICATION; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ACNE VULGARIS; CYTOKINES; DEHYDROEPIANDROSTERONE SULFATE; GROWTH HORMONE; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; MACROPHAGES; MONOCYTES; PROPIONIBACTERIUM ACNES; SEBUM; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 84900527648     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998; 39:S34-7
2. Pochi PE. The Pathogenesis and Treatment of Acne. Annu Rev Med. 1990:187-98. (Pubitemid 20121726)
3. Krowchuk DP Lucky AW. Managing adolescent acne. Adolesc Med. 2001; 12:vii. 355-74.
4. Goulden V. Clark SM, CunliffeWJ. Post-adolescent acne: a review of clinical features. Br J Dermatol. 1997; 136:66-70. (Pubitemid 27016177)
5. Goulden V, Stables Gl, CunliffeWJ. Prevalence of facial acne in adults. J Am Acad Dermatol. 1999:41:577-80. (Pubitemid 29480407)
6. Kim GK, Michaels BB. Post-adolescent acne in women: more common and more clinical considerations. J Drugs Dermatol. 2012; 11:708-13.
7. Holland DB, Jeremy AHT The Role of Inflammation in the Pathogenesis of Acne and Acne Scarring. Semin Cutan Med Surg. 2005; 24:79-83. (Pubitemid 41111815)
8. Holland DB. Jeremy AHT Roberts SG, Seukeran DC. Layton AM, Cunliffe WJ. Clinical and Laboratory Investigations Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. Brit J Dermatol. 2004:72-81. (Pubitemid 38234009)
9. Jeremy AHT, Holland DB, Roberts SG, Thomson KF Cunliffe WJ. Inflammatory Events Are Involved in Acne Lesion Initiation. J Invest Dermatol. 2003:121:20-7. (Pubitemid 36900450)
10. Taylor M, Gonzalez M, Porter R. Pathways to inflammation: acne pathophysiology. Eur J Dermatol. 2011; 21:323-33.
11. Gerber PA, Buhren BA, Steinhoff M, Homey B. Rosacea: The cytokine and chemokine network. The journal of investigative dermatology Symposium proceedings /the Society for Investigative Dermatology, Ine |and| European Society for Dermatological Research 2011; 15:40-7.
12. Janeway C. Immunobiology :the immune system in health and disease. New York: Garland Science; 2005.
13. Sant A, McMichael A. Revealing the role of CD4(+)T cells in viral immunity. J Exp Med. 2012; 209:1391-5.
14. Yamane H, Paul WE. Early signaling events that underlie fate decisions of naive CD4(+)T cells toward distinctT-helper cell subsets. Immunological reviews 2013; 252:12-23.
15. Feili-Hariri M, Falkner DH, Morel PA. Polarization of naive T cells intoThl orTh2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. Jleukoc biol. 2005:78:656-64, (Pubitemid 41292088)
16. Hamilton JA. Stimulation of macrophage prostaglandin and neutral protease production by phorbol esters as a model for the induction of vascular changes associated with tumor promotion. Cancer res. 1980; 40:2273-80. (Pubitemid 10082238)
17. Takeuchi O, Hoshino K, KawaiT et al. Differential roles of TLR2 andTLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999; 11:443-51. (Pubitemid 29504199)
18. Kim J, Ochoa M-T, Krutzik SR, et al. Activation of Toll-Like Receptor 2 in Acne Triggers Inflammatory Cytokine Responses. J Immunol. 2002:169:1535-41. (Pubitemid 34809200)
19. Kim J. Review of the Innate Immune Response in Acne vulgaris: Activation of Toll-Like Receptor 2 in Acne Triggers Inflammatory Cytokine Responses. Dermatol. 2005; 211:193-8. (Pubitemid 41415858)
20. Ji S, Choi Y. Innate immune response to oral bacteria and the immune evasive characteristics of periodontal pathogens. J Periodontal Implant Sci. 2013; 43:3-11.
21. Izadpanah A, Gallo R. Antimicrobial peptides. J Am Acad Dermatol. 2005:52:381-90.
22. Frasca L, Lande R. Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases. Curr Pharm Biotechnol. 2012; 13:1882-97.
23. Melnik BC, Schmitz G. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol. 2009:18:833-41.
24. Sadagurski M, Yakar S, Weingarten G, et al. Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol Cell Biol. 2006; 26:2675-87.
25. Rudman SM, Philpott MR Thomas GA, Kealey T. The role of IGF-I in human skin and its appendages: morphogen as well as mitogen? J Invest Dermatol. 1997; 109:770-7.
26. Cara JF Rosenfield RL, Furlanetto RW. A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child. 1987:141:562-4. (Pubitemid 17054176)
27. Karadag A, Ertugrul D, Tutal E, Akin K. Isotretinoin Influences Pituitary Hormone Levels in Acne Patients. Acta Derm Venereo!. 2011; 91:31-4.
28. Aizawa H, Niimura M. Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol. 1995; 22:249-52.
29. Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005; 141:333-8. (Pubitemid 40365449)
30. Vora S, Ovhal A, Jerajani H, Nair N, Chakrabortty A. Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol. 2008; 159:990-1.
31. Isard O, Knol AC, Aries MF et al. Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation. J Invest Dermatol. 2011; 131:59-66.
32. Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol 2011; 3:41-9.
33. Ottaviani M, Camera E, Picardo M. Lipid mediators in acne. Mediators Intlamm. 2010:2010.
34. Shaheen B, Gonzalez M. Acne sans P acnes. J Eur Acad Dermatol Venereo!. 2013; 27(1):1-10
35. Downing DT, Stewart ME, Wertz PW, Strauss JS. Essential fatty acids and acne. J Am Acad Dermatol. 1986; 14:221-5. (Pubitemid 16068070)
36. Vowels BR, Yang S, Leyden JJ. Induction of Proinflammatory Cytokines by a Soluble Factor of Propionibacterium acnes: Implications for Chronic Inflammatory Acne. Infect and Immun. 1995:63:3158-65.
37. Mastrofrancesco A, Kokot A, Eberle A, et al. KdPT, a tripeptide derivative of alpha-melanocyte-stimulating hormone, suppresses IL-1 beta-mediated cytokine expression and signaling in human sebocytes. J Immunol. 2010; 185:1903-11.
38. Smith TM, Cong Z, Gilliland KL. Clawson GA, Thiboutot DM. Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol. 2006; 126:1226-32. (Pubitemid 43997901)
39. Makrantonaki E, Vogel K, Fimmel S, Oeff M, Seltmann H, Zouboulis CC. Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol. 2008:43:939-46.
40. Choi JJ, Park MY, Lee HJ, et al. TNF-alpha increases lipogenesis via JNK and PI3K/Akt pathways in SZ95 human sebocytes. J Dermatol Sci. 2012; 65:179-88.
41. Smith TM, Gilliland K, Clawson GA. Thiboutot D. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway J Invest Dermatol. 2008:128:1286-93.
42. Mouser PE, Baker BS. Seaton ED, Chu AC. Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris. J Invest Dermatol. 2003; 121:1226-8. (Pubitemid 37431000)
43. Kim J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatol. 2005; 211:193-8. (Pubitemid 41415858)
44. Lee SE, Kim J-M, Jeong SK, et al. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes. Arch Dermatol Res. 2010; 302:745-56.
45. Papakonstantinou E, Aletras A, Glass E, et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol. 2005; 125:673-84.
46. Trivedi NR, Gilliland KL, ZhaoW, Liu W, Thiboutot DM. Gene Array Expression Profiling in Acne Lesions Reveals Marked Upregulation of Genes Involved in Inflammation and Matrix Remodeling. J Invest Dermatol. 2006; 126:1071-9.
47. Lee WJ, Jung HJ, Lim HJ, Jang YH, Lee S-J, Kim DW. Serial sections of atrophic acne scars help in the interpretation of microscopic findings and the selection of good therapeutic modalities. J Eur Acad Dermatol Venereol. 2011:1-4.
48. Davis EC, Callender VD. Postinflammatory Hyperpigmentation A Review of the Epidemiology, Clinical Features, and Treatment Options in Skin of Color. J Clin Aesthetic Dermatol. 2010; 3:20-31.
49. Romagnani S.T-cell subsets (Thl versusTh2). Ann Allergy Asthma Immunol. 2000; 85(1):9-18.